Dialysis News and Research

Latest Dialysis News and Research

Study examines the best type of dialysis access for elderly patients

Elderly patients with kidney failure may not gain the same benefits from what's considered the gold standard for accessing the blood for dialysis compared with younger patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

28 Jun 2013

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.

24 Jun 2013

Administering large iron doses over short period of time increases patients' risk of infections

While intravenous iron is critical for maintaining the health of many dialysis patients, administering large doses over a short period of time increases patients' risk of developing serious infections, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Smaller doses given for a longer period of time appears to be much safer.

24 Jun 2013

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.

21 Jun 2013

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced top line results of the Phase 4 SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin).

20 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

American Ambulance continues to grow and expand in New England region

American Ambulance Service-New England, the premier New England-based provider of emergent and non-emergent ambulance services at both the basic and advanced life support levels, today announced its continued growth and expansion in the New England region.

15 Jun 2013

Teleflex gets FDA clearance to market ARROW NextStep Retrograde Femoral Length Dialysis Catheters

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW NextStep Retrograde Femoral Length Dialysis Catheters.

11 Jun 2013

Whitehead Institute researchers identify drug target for anemia

Researchers at Whitehead Institute have identified a protein that is the target of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.

10 Jun 2013

Doctors create bioengineered blood vessel and implant it in the arm of kidney disease patient

In a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and implanted it into the arm of a patient with end-stage kidney disease.

7 Jun 2013

ZOLL Autopulse improves ROSC after sudden cardiac arrest

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that a paper just published in Critical Care Medicine reported the likelihood of achieving a return of spontaneous circulation (ROSC) after sudden cardiac arrest (SCA) is 62% greater when the AutoPulse® Non-invasive Cardiac Support Pump is used to deliver CPR chest compressions.

7 Jun 2013

End-of-life care: A challenge in terms of costs and quality

t first glance, America is making great strides toward a medical and cultural shift in its approach to end-of-life care: More and more providers are recognizing the benefits of hospice, more people are dying at home, and many health care organizations are institutionalizing the discussions between providers and patients that would help patients formalize their wishes for end-of-life care through an advance directive. But pull up the curtain on these statistics, and the drama that unfolds tells a very different story. End-of-life care continues to be characterized by aggressive medical intervention and runaway costs (Adamopoulos, 6/3).

5 Jun 2013

Paladina Health announces opening of Federal Way clinic in Washington

Paladina Health, LLC, an innovative employer-sponsored medical home health care provider, today announced the opening of the 35th clinic in its growing nationwide network. Located at 32275 32nd Ave. S. in Federal Way, Wash., the clinic is Paladina Health'sTM second in the state.

4 Jun 2013

New test to predict increased risk of death, hospitalization among kidney dialysis patients

Johns Hopkins scientists report that a 10-minute test for "frailty" first designed to predict whether the elderly can withstand surgery and other physical stress could be useful in assessing the increased risk of death and frequent hospitalization among kidney dialysis patients of any age.

29 May 2013

Improved communication could help with end of life decision making, suggests BIDMC research

In any given year, 400,000 Americans suffering from end-stage kidney disease will undergo dialysis, and as many as 20 to 25 percent of those dialysis patients will die, a statistic comparable to many types of cancer.

28 May 2013

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

24 May 2013

Lifestyle behaviors can lower risk of kidney failure in people with CKD

Lifestyle behaviors like working out and improving nutrition can lower the risk of kidney failure in people with chronic kidney disease, according to new research from the University of Alabama at Birmingham.

24 May 2013

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

21 May 2013

Diaverum to present results of latest research work at ERA/EDTA 2013

Diaverum, one of the world's leading renal care service providers, is presenting its service portfolio and the results of its latest research at the ERA/EDTA 2013.

17 May 2013

Robotic transplantation may reduce health disparities for obese patients with chronic kidney failure

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional "open" transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System.

17 May 2013

Dialysis News and Research

Latest Dialysis News and Research

Study examines the best type of dialysis access for elderly patients

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Administering large iron doses over short period of time increases patients' risk of infections

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

European Commission amends marketing authorisation for Celgene's REVLIMID

American Ambulance continues to grow and expand in New England region

Teleflex gets FDA clearance to market ARROW NextStep Retrograde Femoral Length Dialysis Catheters

Whitehead Institute researchers identify drug target for anemia

Doctors create bioengineered blood vessel and implant it in the arm of kidney disease patient

ZOLL Autopulse improves ROSC after sudden cardiac arrest

End-of-life care: A challenge in terms of costs and quality

Paladina Health announces opening of Federal Way clinic in Washington

New test to predict increased risk of death, hospitalization among kidney dialysis patients

Improved communication could help with end of life decision making, suggests BIDMC research

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

Lifestyle behaviors can lower risk of kidney failure in people with CKD

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

Diaverum to present results of latest research work at ERA/EDTA 2013

Robotic transplantation may reduce health disparities for obese patients with chronic kidney failure

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in